Lancaster County pausing use of Johnson & Johnson vaccine
Lancaster County is immediately pausing the use of the Johnson & Johnson vaccine.
LINCOLN, Neb. (KLKN) — Lancaster County is immediately pausing the use of the Johnson & Johnson vaccine.
The announcement from comes after recommendations from the CDC and FDA earlier Tuesday morning.
The agencies are currently reviewing six reports of people who received the J&J vaccine experiencing a rare and severe type of blood clot. One of those six people is a woman in Nebraska.
The cases represent a fraction of the more than 6.8 million doses of Johnson & Johnson vaccine that have been administered nationwide.
LLCHD does not have any clinics scheduled this week to administer the Johnson & Johnson vaccine. All vaccination events previously scheduled to use Johnson & Johnson vaccine will instead use Pfizer or Moderna vaccines.
The health department says the Moderna vaccine will now be provided at the drive-through first-dose vaccination clinics at Gateway Mall on Wednesday, April 14 and Saturday, April 17. The Nebraska Department of Health and Human Services had planned to administer Johnson & Johnson vaccine at those clinics.
LLCHD is in the process of contacting people who have scheduled appointments and letting them know about the change in vaccine.
Just over 11,500 doses of Johnson & Johnson vaccine have been administered in Lancaster County through clinics and the federal retail pharmacy program. It represents about 5% of the vaccines given out to date, according to the county dashboard.
Health officials say they have not received any reports of adverse effects associated with the vaccine at this time.
People who have received the Johnson & Johnson vaccine who develop a severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider and seek medical treatment.